LOS ANGELES, CA--(Marketwired - Oct 5, 2015) - Marathon Patent Group, Inc. (
The PTAB ruled: "We determine that Petitioner fails to demonstrate a reasonable likelihood of prevailing on any of the asserted grounds of unpatentability. In consideration of the foregoing, it is hereby: ORDERED that institution of inter partes review is denied as to all challenged claims of U.S. Patent No. 5,732,375."
"We are pleased with the USPTO's decision denying Honda's petition," said Doug Croxall, Founder and CEO of Marathon Patent Group. "This ruling, along with those that have preceded it, continue to demonstrate the value of our proprietary process to assess, value, and acquire high quality patent assets that have the potential of generating meaningful return on investment for both the company and its shareholders."
The '375 patent is titled "Method of Inhibiting or Allowing Airbag Deployment," and issued on March 24, 1998. The '375 patent discloses techniques for protecting passengers in a front passenger vehicle seat by using seat sensors to determine seat occupancy for controlling airbag deployment.
Signal IP Inc., was represented by the Ascenda Law Group at the PTAB proceedings.
About Marathon Patent Group
Marathon is a patent acquisition and monetization company. The Company acquires patents from a wide-range of patent holders from individual inventors to Fortune 500 companies. Marathon's strategy of acquiring patents that cover a wide-range of subject matter allows the Company to achieve diversity within its patent asset portfolio. Marathon generates revenue with its diversified portfolio through actively managed concurrent patent rights enforcement campaigns. This approach is expected to result in a long-term, diversified revenue stream. To learn more about Marathon Patent Group, visit www.marathonpg.com.
Safe Harbor Statement
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.